Jenny Martin v. Eli Lilly & Co.

702 F. App'x 952
Court of Appeals for the Eleventh Circuit·Decided July 21, 2017·No. 16-11537·Unpublished·Cited by 11 cases

Opinions

BALDOCK, Circuit Judge:

Plaintiff Jenny Martin obtained a jury verdict in her favor on a claim that her former employer, Defendant Eli Lilly & Company (“Lilly”), discriminated against her on the basis of her disability in violation of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12112. Lilly challenges the district court’s denial of its motion for judgment as a matter of law because, in its view, Martin did not suffer an adverse employment action. Exercising jurisdiction under 28 U.S.C. § 1291, we agree with Lilly and reverse.

I.

The parties are familiar with the relevant, facts and procedural history of this case, and we only summarize them here. Martin began working at Lilly in 2001 as a pharmaceutical sales representative. In 2004, Martin transferred from North Carolina to Atlanta, Georgia, and was also diagnosed that same year with major depressive disorder. Beginning in July 2008, Martin worked directly under Darrell Craven in the Neuroscience Account Based [954] Sales (“NABS”) division. For the 2009 and 2010 sales years, Craven submitted negative performance evaluations for Martin based in part on his perception of her emotional intelligence (“EQ”), a subjective measurement used to assess an employee’s awareness of her environment and the impact she has on others. He also gave her “low successful” year-end ratings.

In 2011, Lilly hired ZS Associates to help reorganize its NABS division by downsizing the sales force, drawing new sales territories, and matching existing sales representatives to the newly-drawn territories. Lilly worked with ZS Associates to establish several “business rules” to determine which employees would be automatically placed in the newly-drawn territories and thus would be guaranteed to remain employed after the 2011 reorganization. Relevant here, the third business rule considered each employee’s HR Index score, a newly created tool that reflected a weighted blend of seniority and performance ratings for the previous three years.

As a result of the reorganization, Lilly reduced its regions in Georgia from three to two. Martin lost the northern territory to Bessie Grant, another sales representative whose HR Index score was higher based on slightly more seniority (10.45 years to Martin’s 9.88 years) and her better job performance in 2011 (“successful” versus Martin’s “low successful”). The two had the same ratings in 2009 (“successful”) and 2010 (“low successful”). As a result, Martin was not automatically placed in a newly-drawn territory.

Lilly announced in June 2011 that the reorganization would take place in January 2012, and it encouraged Martin and other soon-to-be-displaced employees to apply for open positions at Lilly. From the announcement in June 2011 until March 2012, Lilly allowed the displaced employees to retain their current positions and also provided them with full salary and benefits. Martin applied for positions in Atlanta and North Carolina and expressed that North Carolina was “geographically closest to where I want to be.” Lilly offered Martin a position as a sales representative in the NABS division in Charlotte, North Carolina, a position for which Martin applied and which would have resulted in Martin working in the same position from which she was displaced—again reporting directly to Craven—but in a different location. Lilly would have paid Martin’s relocation expenses, but Martin declined the position after deciding with her family and health care providers that, for her mental health, she should not continue to report to Craven. When Martin’s employment with Lilly ended in March 2012, she wrote to other Lilly employees that her “heart [wa]s just not in the industry” and that she wanted to leave the pharmaceutical and biotechnology world to pursue her passion. Martin remained in Atlanta and works as a realtor.

Martin filed a complaint against Lilly alleging causes of action under the ADA and the Family and Medical Leave Act (“FMLA”), 29' U.S.C. § 2601 et seq. By granting in part and denying in part Lilly’s motion for summary judgment, the district court narrowed the theories Martin could pursue in her ADA discrimination claim. The district court barred her from pursuing a claim that her eventual termination was an adverse employment action because she failed to exhaust her administrative remedies on that theory. The district court also held that Martin had not made a sufficient showing that Craven’s negative performance evaluations of her disentitled her to a merit raise. But the district court permitted Martin to proceed on a theory that her “negative performance evaluations played a significant role in her displacement from Lilly,”

[955] Martin tried her remaining ADA and FMLA claims to a jury. Lilly moved for judgment as a matter of law on all the claims at the close of Martin’s case-in-chief and again at the close of all the evidence. The district court denied the motion except as to punitive damages. The jury thereafter found in Martin’s favor on only the ADA discrimination claim. The jury did not award any damages for lost wages or benefits, but awarded $600,000 to compensate Martin for emotional pain and mental anguish caused by the adverse employment action.1 After trial, Lilly renewed its motion for judgment as a matter of law under Federal Rule of Civil Procedure 50 and filed an alternative Rule 59 motion for new trial. The district court denied the motions but remitted the compensatory damages award to the statutory cap of $300,000.

II.

Free access — add to your briefcase to read the full text and ask questions with AI

Jenny Martin v. Eli Lilly & Co., 702 F. App'x 952 (11th Cir. 2017).

702 F. App'x 952 (Jenny Martin v. Eli Lilly & Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related